肠道微生物群代谢物在治疗COPD中的潜力:网络药理学和门德尔随机化方法
Zhenghua Cao1, Shengkun Zhao1, Tong Wu2
1Graduate School, Changchun University of Chinese Medicine, Changchun, Jilin, China.
Frontiers in microbiology
|December 10, 2024
概括
肠道微生物群影响慢性阻塞性肺病 (COPD). 作为肠道代谢产物的甲胺显示,与COPD有因果关系,为潜在的新治疗策略提供了机会.
科学领域:
- 微生物组研究的研究.
- 肺部医学 肺部医学
- 代谢学 代谢学 代谢学
背景情况:
- 肠道微生物群及其代谢物显著影响慢性阻塞性肺病 (COPD).
- 这种影响背后的确切机制在很大程度上是未知的.
- 了解这些相互作用对于开发新的治疗策略至关重要.
研究的目的:
- 综合调查肠道微生物群和COPD中的代谢物的作用和机制.
- 为了确定与COPD发展和进展有因果关系的特定微生物代谢物.
主要方法:
- 网络药理学被用来绘制COPD肠道微生物群,代谢物,标和信号通路之间的复杂相互作用.
- 门德尔的随机化被用来推断确定肠道微生物群代谢物和COPD之间的因果关系.
主要成果:
- 一个生物网络揭示了39种肠道微生物,20种途径,19个目标和23种与COPD相关的代谢物.
- 甲基胺被确定为一种关键代谢物,与COPD有显著的因果关系.
- 这种代谢物是COPD干预的有希望的目标.
结论:
- 这项研究阐明了复杂的肠道微生物群-代谢物-COPD轴.
- 甲基胺成为COPD的潜在新型治疗点.
- 这些发现可能有助于早期识别COPD的风险,预防和治疗策略.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178
COPD: Pathogenesis and Clinical Features
232
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
232
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K


